AEON Biopharma (AEON) Net Equity Issued and Repurchased (2021 - 2025)
AEON Biopharma (AEON) posted Net Equity Issued and Repurchased of -$18.3 million for Q4 2025, down 6187.33% sequentially from $300000.0 in Q3 2025, and down 18926.8% YoY from N/an in Q4 2024.
AEON Biopharma (AEON) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
AEON Biopharma has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at -$18.3 million in Q4 2025.
- Quarterly Net Equity Issued and Repurchased fell 18926.8% year-over-year to -$18.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $481000.0 (up 395.88% YoY) and the FY2025 annual result came in at $1.8 million, up 1118.37% from the prior year.
- Net Equity Issued and Repurchased declined to -$18.3 million in Q4 2025 per AEON's latest filing, from $300000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $270.5 million in Q1 2021 and troughed at -$18.3 million in Q4 2025.
- A 3-year average of $54.2 million and a median of $300000.0 in 2025 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 18926.8% in 2025, down 18926.8% in 2025.
- Over 3 years, Net Equity Issued and Repurchased stood at $270.5 million in 2021, then sank by 99.96% to $97000.0 in 2024, then tumbled by 18926.8% to -$18.3 million in 2025.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$18.3 million, $300000.0, and $18.3 million for Q4 2025, Q3 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.26 Mn |
| Dec 31, 2025 | -18.26 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 18.35 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Mar 31, 2021 | 270.48 Mn |
| Mar 31, 2021 | 270.48 Mn |